Date published: 2025-10-25

1-800-457-3801

SCBT Portrait Logo
Seach Input

SPEER-4E Inhibitors

SPEER-4E inhibitors refer to a specialized class of chemical agents designed to selectively interact with the SPEER-4E molecular structure. SPEER-4E, an acronym that would typically detail the specific molecular target, suggests a particular protein or enzyme recognized by these inhibitors. The precise mechanism of action for these inhibitors would involve the binding to the active or allosteric sites of the SPEER-4E protein, thereby modulating its function. This interaction is characterized by a high degree of specificity, ensuring that the inhibitor has a strong affinity for the SPEER-4E protein, which is often crucial to achieve the desired level of molecular interaction without affecting other biological pathways. The inhibitors' design is based on the unique three-dimensional configuration of the SPEER-4E protein, taking into account the distribution of charge, hydrophobic and hydrophilic regions, and the dynamic conformational states of the protein to ensure effective binding.

The development of SPEER-4E inhibitors is a complex process that involves a deep understanding of the structure-activity relationships (SAR) governing the interaction between the inhibitor and the SPEER-4E protein. This includes the identification of key functional groups within the inhibitor molecule that are responsible for binding, the optimization of these functional groups to enhance affinity and selectivity, and the assessment of the inhibitor's stability and reactivity within a biological environment. Advanced techniques such as computer-aided drug design (CADD), X-ray crystallography, and nuclear magnetic resonance (NMR) spectroscopy are often employed to elucidate the details of the interaction at an atomic level. The chemical synthesis of SPEER-4E inhibitors may involve multiple steps to construct the inhibitor molecule with high purity and yield. Moreover, the physicochemical properties of the inhibitors, such as solubility, permeability, and metabolic stability, are fine-tuned to ensure that they can maintain their integrity in the complex milieu of a biological system.

SEE ALSO...

Items 1 to 10 of 12 total

Display:

Product NameCAS #Catalog #QUANTITYPriceCitationsRATING

Rapamycin

53123-88-9sc-3504
sc-3504A
sc-3504B
1 mg
5 mg
25 mg
$62.00
$155.00
$320.00
233
(4)

An mTOR inhibitor that reduces the activity of the mTORC1 complex, which could downregulate the translation of SPEER-4E by inhibiting downstream signaling pathways involved in protein synthesis.

LY 294002

154447-36-6sc-201426
sc-201426A
5 mg
25 mg
$121.00
$392.00
148
(1)

A PI3K inhibitor that impedes the PI3K/Akt/mTOR pathway, potentially decreasing the synthesis and activity of SPEER-4E by inhibiting downstream signals required for its expression.

Wortmannin

19545-26-7sc-3505
sc-3505A
sc-3505B
1 mg
5 mg
20 mg
$66.00
$219.00
$417.00
97
(3)

Another PI3K inhibitor, which could lead to reduced activity of SPEER-4E by blocking PI3K/Akt/mTOR signaling, thereby potentially lowering the expression and function of SPEER-4E.

PD 98059

167869-21-8sc-3532
sc-3532A
1 mg
5 mg
$39.00
$90.00
212
(2)

A MEK inhibitor that obstructs the MEK/ERK pathway, potentially leading to decreased phosphorylation events that could otherwise enhance the stability or activity of SPEER-4E.

SB 203580

152121-47-6sc-3533
sc-3533A
1 mg
5 mg
$88.00
$342.00
284
(5)

A p38 MAPK inhibitor that could reduce the functional activity of SPEER-4E by inhibiting the p38 MAPK pathway, which may be involved in the stress response regulation of SPEER-4E.

SP600125

129-56-6sc-200635
sc-200635A
10 mg
50 mg
$40.00
$150.00
257
(3)

An inhibitor of JNK, which could lead to a decrease in SPEER-4E activity if SPEER-4E is regulated by stress-activated pathways that involve JNK signaling.

Dasatinib

302962-49-8sc-358114
sc-358114A
25 mg
1 g
$47.00
$145.00
51
(1)

A Src kinase inhibitor that could impede upstream signals that enhance the activity or stability of SPEER-4E, thereby leading to its decreased functional activity.

Bortezomib

179324-69-7sc-217785
sc-217785A
2.5 mg
25 mg
$132.00
$1064.00
115
(2)

A proteasome inhibitor that could lead to decreased activity of SPEER-4E by enhancing the degradation of improperly folded SPEER-4E proteins or its regulatory proteins.

U-0126

109511-58-2sc-222395
sc-222395A
1 mg
5 mg
$63.00
$241.00
136
(2)

Another MEK inhibitor that could decrease the activation of ERK1/2 and subsequently reduce the functional activity of SPEER-4E if it is regulated through this pathway.

Cycloheximide

66-81-9sc-3508B
sc-3508
sc-3508A
100 mg
1 g
5 g
$40.00
$82.00
$256.00
127
(5)

An inhibitor of eukaryotic protein synthesis that could decrease the overall levels of SPEER-4E by blocking its translation on ribosomes.